3-ATA (NSC 680434) is a selective inhibitor of cyclin-dependent kinase 4 ( CDK4 ) with neuroprotective and antitumor effects. 3-ATA can alleviate kainic acid ( HY-N2309 )-induced apoptosis in cerebellar granule neurons, which can be used in the study of neurodegenerative diseases.
Products | Products > Disease Areas > Cancer | Products > Disease Areas > Neurological, Eye or Ear Disease | Products > Signaling Pathways > Apoptosis | Products > Signaling Pathways > Cell Cycle/DNA Damage | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Research Areas > Neurological Disease | Products > Research Areas > Cancer | Products > Signaling Pathways > Apoptosis | Products > Signaling Pathways > CDK
Please leave a message for us or use the following ways to contact us, we will reply to you as soon as possible, and provide you with the most sincere service, thank you.